Despite recommendations from health care professionals, most patients with asthma do not track their symptoms, leaving limited data to help them discuss care options with their clinicians. JAMA Associate Editor Yulin Hswen, ScD, MPH, spoke with Robert S. Rudin, PhD, a senior information scientist at RAND, and a professor of policy analysis at the Pardee RAND Graduate School, about a randomized clinical trial published in JAMA Network Open examining the potential benefits of using AI for between-visit asthma symptom monitoring. Related Content:

• Between-Visit Asthma Symptom Monitoring With a Scalable Digital Intervention
• Discussing Digital Interventions in Asthma Symptom Monitoring